Fate Therapeutics, Inc.

FATE ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2024

Total Assets: $440.7M

Liabilities Breakdown FY2024

Total Liabilities: $122.0M